Smoking increases the risk of a number of diseases, including
cardiovascular,
oral, and lung diseases. E-cigarettes are gaining popularity among
young people as an alternative to cigarettes, but there is debate
over whether they are less harmful to the mouth than e-cigarettes.
In this study, human gingival epithelial cells (HGECs) were treated
with four commercially available e-cigarette aerosol condensates (ECAC)
or commercially available generic cigarette smoke condensates (CSC)
with different nicotine concentrations. Cell viability was determined
by MTT assay. Cell apoptosis was observed by acridine orange (AO)
and Hoechst33258 staining. The levels of type I collagen, matrix metalloproteinase
(MMP-1, MMP-3), cyclooxygenase 2, and inflammatory factors were detected
by ELISA and RT-PCR. Finally, ROS levels were analyzed by ROS staining.
The different effects of CSC and ECAC on HGECs were compared. The
results showed that higher nicotine concentration of CS significantly
reduced the activity of HGECs. By contrast, all ECAC had no significant
effect. The levels of matrix metalloproteinase, COX-2, and inflammatory
factors were higher in HGECs treated with CSC than those treated with
ECAC. In contrast, the level of type I collagen was higher in HGECs
treated with ECAC than those treated with CSC. In conclusion, all
four flavors of e-cigarettes were less toxic to HGE cells than tobacco,
but further clinical studies are needed to determine whether e-cigarettes
are less harmful to oral health than conventional cigarettes.